ENDRA Life Sciences Inc.·4

Nov 28, 5:00 PM ET

Tokman Alexander Y 4

4 · ENDRA Life Sciences Inc. · Filed Nov 28, 2022

Insider Transaction Report

Form 4
Period: 2022-11-23
Tokman Alexander Y
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2022-11-23$0.17/sh+10,000$1,700162,857 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION